Science
Letizia Pontolillo
Letizia Pontolillo/LinkedIn

Letizia Pontolillo Shares ctDNA Study in HR+/HER2– Metastatic Breast Cancer

Letizia Pontolillo, MD, Research Fellow at Weill Cornell Medicine, shared a post on LinkedIn about a published on Nature:

“Excited to share our multicenter, real-world ctDNA study in HR+/HER2– metastatic breast cancer, now published in NPJ Breast Cancer.”

Title: Circulating genomic landscape following cyclin-dependent kinase 4/6 inhibitors exposure in HR + /HER2− metastatic breast cancer: a retrospective multi-institutional Consortium analysis

Authors: Letizia Pontolillo, Andrew A. Davis, Lorenzo Gerratana, Arielle J. Medford, Judy Wang, Eleonora Nicolo’, Katherine Clifton, Marko Velimirovic, Surbhi Warrior, Emily Podany, Eleni Andreopoulou, Mara Serena Serafini, Laura Munoz-Arcos, Elisabetta Molteni, Marla Lipsyc-Sharf, Caterina Gianni, Nadia Bayou, Charles S. Dai, Diana Giannarelli, Emilio Bria, Cynthia X. Ma, Aditya Bardia, Carolina Reduzzi and Massimo Cristofanilli

Read the full article.

Letizia Pontolillo

More posts featuring Letizia Pontolillo on OncoDaily.

Aditya Bardia Andrew A Davis Arielle J. Medford cancer Carolina Reduzzi Caterina Gianni Charles S Dai Cynthia X. Ma Diana Giannarelli Eleni Andreopoulou Eleonora Nicolò Elisabetta Molteni Emilio Bria Emily Podany Judy Wang Katherine Clifton Laura Munoz-Arcos Letizia Pontolillo Lorenzo Gerratana Mara Serena Serafini Marko Velimirovic Marla Lipsyc-Sharf Massimo Cristofanilli Nadia Bayou Nature OncoDaily Oncology Surbhi Warrior Weill Cornell Medicine